[1]
S. Kaasa, MD, PhD, K. Moksnes, MD, T. Nolte, MD, D. Lefebvre-Kuntz, MD, L. Popper, MS, PhD, and H. G. Kress, MD, PhD, “Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain”, J of Opioid Management, vol. 6, no. 1, pp. 17–26, Jan. 2018.